Patients with rheumatic diseases are at increased risk of infectious complications;
vaccinations are a critical component of their care. Disease-modifying antirheumatic drugs …

Background Although accumulating data have suggested the development of cancer in
systemic lupus erythematosus (SLE) patients, these results remain inconsistent. To examine …

Certain population groups are known to have higher than average anal cancer risk, namely
persons living with HIV (PLHIV), men who have sex with men (MSM), women diagnosed …

Objectives Develop recommendations for women's health issues and family planning in
systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Methods …

The current treatment approach for systemic lupus erythematosus (SLE), as outlined in the
recommendations by international medical associations including EULAR and the ACR, is …

Background Cancer incidence and mortality have received critical attention during the long‐
term management of morbidities in patients with autoimmune diseases (AIDs). This study …

The risk of cervical cancer (CC) among women immunosuppressed for a variety of reasons
is well documented in the literature. Although there is improved organ function, quality of life …

Background Malignancy is a potential comorbidity in patients with systemic lupus
erythematosus (SLE). However, risk by malignancy type remains to be fully elucidated. We …

Objective The incidence of anal cancer is higher in women than men in the general
population and has been increasing for several decades. Similar to cervical cancer, most …

For decades, it has been known that patients with certain autoimmune and inflammatory
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …